Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19

被引：0
|
作者：
Tarek Mohamed Abd El-Aziz
Ahmed Al-Sabi
James D. Stockand
机构：
[1] University of Texas Health Science Center at San Antonio,Department of Cellular and Integrative Physiology
[2] Minia University,Zoology Department, Faculty of Science
[3] American University of the Middle East,College of Engineering and Technology
来源：
Signal Transduction and Targeted Therapy | / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
    Abd El-Aziz, Tarek Mohamed
    Al-Sabi, Ahmed
    Stockand, James D.
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [2] Human recombinant soluble ACE2 in severe COVID-19
    Zoufaly, Alexander
    Poglitsch, Marko
    Aberle, Judith H.
    Hoepler, Wolfgang
    Seitz, Tamara
    Traugott, Marianna
    Grieb, Alexander
    Pawelka, Erich
    Laferl, Hermann
    Wenisch, Christoph
    Neuhold, Stephanie
    Haider, Doris
    Stiasny, Karin
    Bergthaler, Andreas
    Puchhammer-Stoeckl, Elisabeth
    Mirazimi, Ali
    Montserrat, Nuria
    Zhang, Haibo
    Slutsky, Arthur S.
    Penninger, Josef M.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (11): : 1154 - 1158
  • [3] Human recombinant soluble ACE2 in severe COVID-19 (vol 8, pg 1154, 2020)
    Zoufaly, A.
    Poglitsch, M.
    Aberle, J. H.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (11): : E78 - E78
  • [4] ACE2 Elevation in Severe COVID-19
    Wagner, Annkatrin
    PNEUMOLOGIE, 2021, 75 (07): : 494 - 494
  • [5] ACE2 Elevation in Severe COVID-19
    Reindl-Schwaighofer, Roman
    Hoedlmoser, Sebastian
    Eskandary, Farsad
    Poglitsch, Marko
    Bonderman, Diana
    Strassl, Robert
    Aberle, Judith H.
    Oberbauer, Rainer
    Zoufaly, Alexander
    Hecking, Manfred
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09) : 1191 - 1196
  • [6] The ACE2 as a “rescue protein” or “suspect enzyme” in COVID-19: possible application of the “engineered inactive hrsACE2” as a safer therapeutic agent in the treatment of SARS-CoV-2 infection
    Reza Khodarahmi
    Babak Sayad
    Mahsa Sobhani
    Journal of the Iranian Chemical Society, 2021, 18 : 495 - 502
  • [7] Soluble ACE2 as a potential therapy for COVID-19
    Krishnamurthy, Sudarshan
    Lockey, Richard F.
    Kolliputi, Narasaiah
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2021, 320 (03): : C279 - C281
  • [8] The ACE2 as a "rescue protein" or "suspect enzyme" in COVID-19: possible application of the "engineered inactive hrsACE2" as a safer therapeutic agent in the treatment of SARS-CoV-2 infection
    Khodarahmi, Reza
    Sayad, Babak
    Sobhani, Mahsa
    JOURNAL OF THE IRANIAN CHEMICAL SOCIETY, 2021, 18 (03) : 495 - 502
  • [9] Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses
    Lebedin, Mikhail
    Ratswohl, Christoph
    Garg, Amar
    Schips, Marta
    Garcia, Clara Vazquez
    Spatt, Lisa
    Thibeault, Charlotte
    Obermayer, Benedikt
    Weiner III, January
    Velasquez, Ilais Moreno
    Gerhard, Cathrin
    Stubbemann, Paula
    Hanitsch, Leif -Gunnar
    Pischon, Tobias
    Witzenrath, Martin
    Sander, Leif Erik
    Kurth, Florian
    Meyer-Hermann, Michael
    de la Rosa, Kathrin
    ISCIENCE, 2024, 27 (03)
  • [10] Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients
    Rahman, Mohammad Mahmudur
    Hasan, Maruf
    Ahmed, Asif
    REVIEWS IN MEDICAL VIROLOGY, 2021, 31 (05) : 1 - 12
12345